Position in CHRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,159,793
-$115,673 QoQ
Shares Held
3,685,567
+18.1% QoQ
Ownership
2.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,496,892 across 520 Biotechnology names. CHRS ranks #238 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in CHRS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,159,793 | 3,685,567 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $5,275,466 | 3,121,578 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,898,248 | 2,745,246 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $4,495,610 | 2,741,226 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,956,503 | 2,676,476 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,142,987 | 2,655,500 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,587,501 | 2,599,639 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,667,750 | 2,565,145 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,121,259 | 2,382,231 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $5,266,828 | 2,203,694 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $6,931,731 | 2,081,601 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $7,274,176 | 1,944,967 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,065,996 | 1,420,608 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,949,250 | 1,308,370 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,982,526 | 1,260,420 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $11,812,698 | 1,229,209 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,665,208 | 1,196,852 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $15,079,602 | 1,168,056 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,068,369 | 1,194,760 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $19,248,388 | 1,197,784 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,368,745 | 1,183,568 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,060,933 | 1,099,311 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $17,162,228 | 987,470 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $17,570,820 | 958,060 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $17,055,567 | 954,959 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $15,716,888 | 968,982 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||